Jiangsu vcare pharmaceutical technology co., LTD   Report issue

For profit Phase 1 Phase 2
Founded: Jiangsu China (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2018
NCT03599284
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Jiangsu vcare pharmaceutical technology co., LTD

Active Ingredients

Drugs in Phase 2 Trials (5)

clopidogrel (plavix) (3 trials)

tofacitinib (xeljanz) (1 trial)

vc004 (2 trials)

vc005 (6 trials)

vicagrel (6 trials)

Drugs in Phase 1 Trials (1)

omeprazole (prilosec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 14
  • # of Trial APIs: 6